Canopy Growth Corp (CGC) stock
CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
$0.53−0.01 (-2.67%)
Close on Nov 17, 2026Market cap $224.80MP/E –Yield –
Canopy Growth total assets
Total assets on the balance sheet at the end of each period.
Canopy Growth's total assets was C$1.10B at Jun 30, 2026. For fiscal 2026 it was C$1.12B, up 21.9% from the year before. The highest annual figure on record is C$8.57B in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | C$1.12B | +21.9% |
| FY2025 | Mar 31, 2025 | C$917.70M | -29.4% |
| FY2024 | Mar 31, 2024 | C$1.30B | -46.7% |
| FY2023 | Mar 31, 2023 | C$2.44B | -56.5% |
| FY2022 | Mar 31, 2022 | C$5.61B | -17.9% |
| FY2021 | Mar 31, 2021 | C$6.82B | -0.5% |
| FY2020 | Mar 31, 2020 | C$6.86B | -19.9% |
| FY2019 | Mar 31, 2019 | C$8.57B | +496.1% |
| FY2018 | Mar 31, 2018 | C$1.44B | +104.5% |
| FY2017 | Mar 31, 2017 | C$702.72M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | C$1.10B | +22.0% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | C$1.12B | +21.9% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | C$1.11B | -5.0% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | C$1.07B | -13.2% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | C$904.67M | -29.7% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | C$917.70M | -29.4% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | C$1.16B | -14.4% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | C$1.23B | -26.1% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | C$1.29B | -41.3% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | C$1.30B | -46.7% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | C$1.36B | -53.7% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | C$1.67B | -49.7% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | C$2.19B | -37.5% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | C$2.44B | -56.5% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | C$2.94B | -53.4% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | C$3.32B | -48.9% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | C$3.50B | -49.7% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | C$5.61B | -17.9% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | C$6.31B | -0.0% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | C$6.49B | -1.3% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | C$6.97B | +1.8% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | C$6.82B | -0.5% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | C$6.31B | -26.3% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | C$6.57B | +357.5% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | C$6.85B | +874.2% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | C$6.86B | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | C$8.57B | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | C$1.44B | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | C$702.72M | – |
See a number that looks wrong?